1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Typhoid Fever Vaccines Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Typhoid Fever Vaccines Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Typhoid Fever Vaccines Market Regional Analysis
6.2 North America Typhoid Fever Vaccines Market Revenue 2017-2027 (US$ Million)
6.3 North America Typhoid Fever Vaccines Market Forecast Analysis
7. North America Typhoid Fever Vaccines Market Analysis – by Vaccine Type
7.1 Live Attenuated Vaccine
- 7.1.1 Overview
- 7.1.2 Live Attenuated Vaccine: North America Typhoid Fever Vaccines Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Capsular Polysaccharide Vaccines
- 7.2.1 Overview
- 7.2.2 Capsular Polysaccharide Vaccines: North America Typhoid Fever Vaccines Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.3 Conjugate Vaccine
- 7.3.1 Overview
- 7.3.2 Conjugate Vaccine: North America Typhoid Fever Vaccines Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. North America Typhoid Fever Vaccines Market Analysis – by Route of administration
8.1 Oral and Injectable
- 8.1.1 Overview
- 8.1.2 Oral and Injectable: North America Typhoid Fever Vaccines Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. North America Typhoid Fever Vaccines Market – North America Analysis
9.1 Overview
9.2 North America
- 9.2.1 North America Typhoid Fever Vaccines Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 9.2.1.1 North America Typhoid Fever Vaccines Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 US:
North America Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.1.1 US: North America Typhoid Fever Vaccines Market Breakdown, by Vaccine Type
- 9.2.1.1.2 US: North America Typhoid Fever Vaccines Market Breakdown, by Route of administration
- 9.2.1.2 Canada:
North America Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.2.1 Canada: North America Typhoid Fever Vaccines Market Breakdown, by Vaccine Type
- 9.2.1.2.2 Canada: North America Typhoid Fever Vaccines Market Breakdown, by Route of administration
- 9.2.1.3 Mexico :
North America Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.3.1 Mexico : North America Typhoid Fever Vaccines Market Breakdown, by Vaccine Type
- 9.2.1.3.2 Mexico : North America Typhoid Fever Vaccines Market Breakdown, by Route of administration
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Sanofi
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 GlaxoSmithKline plc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Paxvax Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Prokarium Ltd
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Scandinavian Biopharma
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Get Free Sample For North America Typhoid Fever Vaccines Market
